PK
Pankaj Kumar Jha
About Pankaj Kumar Jha
Data last updated:
Pankaj Kumar Jha is a Director at Abbott Pharma Limited (since 2018). The companies operate in Healthcare and Pharma. Abbott Pharma Limited reported revenue of ₹47,899 (FY 2026). Earlier, Pankaj Kumar Jha was a Director at Unosource Pharma Limited (2013–2014).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Abbott Pharma Limited U24232DL2008PLC177143 | Director | 08 Jun 2018 | 2008 | ₹47,899 (FY 2026) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Unosource Pharma Limited U24233DL2013PLC262364 | Director | 18 Dec 2013 | 2013 | ₹154 Cr (FY 2026) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Pankaj Kumar Jha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Man Mohan Sharma | 09769105 | Abbott Pharma Limited | Director |
| Neetika Goel | 09030741 | Abbott Pharma Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pankaj Kumar Jha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pankaj Kumar Jha
Pankaj Kumar Jha currently holds 1 directorship: Abbott Pharma Limited (Director, since 08 Jun 2018, revenue ₹47,899 (FY 2026)).
Pankaj Kumar Jha was first appointed on 18 Dec 2013 as Director at Unosource Pharma Limited. The most recent appointment on record is 08 Jun 2018 at Abbott Pharma Limited.
Pankaj Kumar Jha held 1 earlier board appointment: Unosource Pharma Limited (Director, 18 Dec 2013 to 10 Jul 2014).
The current boards of Pankaj Kumar Jha's companies include Man Mohan Sharma (Abbott Pharma Limited), Neetika Goel (Abbott Pharma Limited).